心力衰竭和慢性病之间的相互作用
Anuradha Lala1, Adeera Levin2, Kamlesh Khunti3
1Department of Population Health Science, Icahn School of Medicine, New York, New York, USA.
Diabetes, obesity & metabolism
|April 22, 2025
概括
慢性病 (CKD) 和心力衰竭 (HF) 经常并存,相互恶化. 有效的管理需要认识到它们的系统联系,并利用特定的药物和生活方式的改变.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 心脏病学 心脏病学
- 内部医学 内部医学
背景情况:
- 慢性病 (CKD) 和心力衰竭 (HF) 是普遍存在的,具有双向关系的独立条件.
- 慢性瘤和高瘤经常共存,显著增加患者的发病率,死亡率,住院率,并影响生活质量.
- 常见的CKD和HF风险因素包括晚年,糖尿病,高血压,肥胖和吸烟.
研究的目的:
- 审查CKD和HF之间的相互作用.
- 强调这些共存条件的系统性质.
- 突出卫生保健专业人员在管理CKD和HF患者中的作用.
主要方法:
- 文献综述讨论CKD和HF的相互联系.
- 分析共享的风险因素和病理生理机制.
- 对同时存在的CKD和HF治疗策略的检查.
主要成果:
- 大约50%的HF患者也患有CKD.
- 结核病和肝炎的共存导致不良结果的风险比单独的任何一种情况都要高得多.
- 了解这些疾病的全身性质对于有效治疗至关重要.
结论:
- 慢性脏病和肝炎是系统性疾病,疾病周期相互交织.
- 综合管理策略对于患有CKD和HF的患者至关重要.
- 关键的治疗药物包括氨酸 - ангиотензин 系统抑制剂,SGLT2 抑制剂,芬瑞和GLP-1 受体激动剂,以及生活方式的改变.
相关概念视频
Heart Failure Drugs: Diuretics
349
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
349
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
396
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
396
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Chronic Kidney Disease IV: Nursing Management
2
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
2
Chronic Kidney Disease III: Interprofessional Care
2
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
2
Heart Failure VI: Adjunct Therapies
5
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
5


